D
DayTwo
Precision medicine company developing personalized nutrition, diagnostic, and therapeutic solutions
About DayTwo
In 2015, DayTwo was founded by Yuval Ofek, Lihi Segal, and Marius Nacht, driven by a vision to revolutionize personalized nutrition through gut microbiome science. The company set out to tackle metabolic diseases by offering precision nutrition solutions, leveraging advanced AI and virtual clinical support.
Read full description
DayTwo's journey began with a focus on understanding the gut microbiome's role in metabolic health. By analyzing the microbiome, they aimed to provide personalized dietary recommendations to improve health outcomes for individuals with conditions like diabetes and obesity.
Over the years, DayTwo attracted significant attention from investors, culminating in a series of funding rounds that fueled its growth. The company successfully raised capital to expand its research capabilities and enhance its technological infrastructure, positioning itself as a leader in the precision nutrition space.
In its quest to provide sustainable solutions for metabolic diseases, DayTwo invested heavily in laboratory facilities and cutting-edge technology. This commitment to innovation enabled them to offer a unique approach to managing chronic health conditions, setting them apart from traditional healthcare models.
DayTwo's impact on the healthcare industry has been profound, as they continue to push the boundaries of what's possible in personalized nutrition. By focusing on the gut microbiome, they have opened new avenues for improving health and wellness, offering hope to millions affected by metabolic diseases.
At a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- Walnut Creek, United States
- Employees
- 16
- Open positions
- None listed
- Dealroom signal
- 67.5/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Personal Health, Diabetes, Analytics, Biotechnology, Weight Management, Microbiology
- Technology
- Artificial Intelligence, Deep Tech, Machine Learning, Mobile app
- Business model
- Marketplace & ecommerce
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | May 2021 | $37M | $148M | Cathay Innovation · Micron Ventures · 10D · La Maison Partners | ↗ |
| SERIES BOther financing | Oct 2019 | $5M | $20M | Cathay Innovation · Samsung Next · Longliv Ventures | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for DayTwo is 1K monthly website visits, down 16.7% over the last three months. DayTwo's team declined 11.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Omri Casspi
Series A10 investors entered at this stage
Johnson & Johnson
Seventure Partners
Mayo Clinic
Johnson & Johnson Development Corporation
Marius Nacht
aMoon Fund
10D
Longliv Ventures
Cathay Innovation
Samsung Next
Series B and later4 investors entered at this stage
Micron Ventures
La Maison Partners
Poalim Capital Markets- YSYair Schindel
Other known investors2 additional known investors
Google for Startups Accelerator
Weizmann Institute of Science
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about DayTwo on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See DayTwo’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.